Skip to main content

ORIGINAL RESEARCH article

Front. Genet.
Sec. Genetics of Common and Rare Diseases
Volume 15 - 2024 | doi: 10.3389/fgene.2024.1266210

Rare exonic CELSR3 variants identified in Bladder Exstrophy Epispadias Complex

Provisionally accepted
Angie C. Jelin Angie C. Jelin 1*Nikolai Sopko Nikolai Sopko 1Nara Sobreira Nara Sobreira 1Simeon A. Boyadjiev Simeon A. Boyadjiev 2Elizabeth Wohler Elizabeth Wohler 1Christian Morrill Christian Morrill 1Dane Witmer Dane Witmer 1Jason Michaud Jason Michaud 1David Valle David Valle 3John Gearhart John Gearhart 1Heather Dicarlo Heather Dicarlo 1
  • 1 The Johns Hopkins Hospital, Johns Hopkins Medicine, Baltimore, Maryland, United States
  • 2 University of California, Davis, Davis, California, United States
  • 3 Johns Hopkins Medicine, Johns Hopkins University, Baltimore, Maryland, United States

The final, formatted version of the article will be published soon.

    Introduction/background: Bladder exstrophy epispadias complex (BEEC) is a rare congenital anomaly of unknown etiology, although, genetic and environmental factors have been associated with its development. Variants in several genes expressed in the urogenital pathway have been reported as causative for bladder exstrophy in human and murine models. The expansion of next generation sequencing and molecular genomics has improved our ability to identify the underlying genetic causes of similarly complex diseases and could thus assist with the investigation of the molecular basis of BEEC.Objective: The objective was to identify the presence of rare heterozygous variants in genes previously implicated in bladder exstrophy and correlate them with the presence or absence of bladder regeneration in our study population.Patients and Methods: We present a case series of patients with BEEC whom had bladder biopsies performed by pediatric urology during bladder neck reconstruction or bladder augmentation. Cases were classified as "sufficient" or "insufficient" based on a bladder volume of greater than or less than 40% of expected bladder size. Control bladder tissue specimens were obtained from patients undergoing biopsies for conditions other than bladder exstrophy. Whole exome sequencing was performed on the specimens and the identified variants were compared. Based on the hypothesis of de novo mutations, as well as the potential implications of autosomal dominant conditions with incomplete penetrance, each case was evaluated for autosomal dominant variants in a set of genes previously implicated in BEEC.Results: Whole exome sequencing was performed on DNA extracted from bladder tissue from 5 cases classified as sufficient, 7 cases classified as insufficient, and 6 controls. Our review of the literature identified 44 genes that have been implicated in human models of bladder exstrophy. Our whole exome sequencing data analysis identified rare variants in 2 genes among the cases classified as sufficient, and 7 variants in 5 genes among the cases classified as insufficient.We identified rare variants in previously implicated genes in the majority of our BEEC specimens. Our findings could have implications for prognostic counseling. Additional research is needed to further understand the cellular signaling underlying this potentially genetically heterogeneous embryological condition.

    Keywords: Bladder Exstrophy, genetic variants, Celsr3, exome sequence, Bladder growth

    Received: 28 Jul 2023; Accepted: 28 Mar 2024.

    Copyright: © 2024 Jelin, Sopko, Sobreira, Boyadjiev, Wohler, Morrill, Witmer, Michaud, Valle, Gearhart and Dicarlo. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Angie C. Jelin, The Johns Hopkins Hospital, Johns Hopkins Medicine, Baltimore, 21218, Maryland, United States

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.